Last reviewed · How we verify

NCT07193069

Clinical and Biological Signs of Dapagliflozin Overdose in ICU Patients With Metformin Poisoning

Recruiting now Last updated 25 September 2025
What this trial tests

trial in Drug Overdose in 50 participants. Currently enrolling.

Timeline
11 April 2025
Primary endpoint
11 April 2026
11 April 2026

Quick facts

Lead sponsorCentre Hospitalier de Saint-Denis
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment50
Start date11 April 2025
Primary completion11 April 2026
Estimated completion11 April 2026
Sites1 location across France

Conditions studied

Sponsor

Centre Hospitalier de Saint-Denis

Who can join

18 and older, any sex, with Drug Overdose or Metformin. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study looks at patients admitted to intensive care for drug poisoning involving metformin, a common diabetes medication. Researchers will compare two groups: patients who overdosed on metformin alone and those who took both metformin and dapagliflozin, another diabetes drug. The goal is to find clinical or laboratory signs that could help doctors quickly recognize a dapagliflozin overdose in this context, which could improve treatment and patient outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Drug Overdose

Currently open trials in the same condition.

Other Centre Hospitalier de Saint-Denis trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07193069.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing